Why the study?
Does perioperative beta-adrenergic blockade reduce cardiac morbidity and mortality in adults undergoing major non-cardiac vascular surgery?
Population
599 adults (over 18 years of age) undergoing major non-cardiac vascular surgery (pooled from 2 RCTs)
Comparison
Perioperative beta-adrenergic blockade vs Placebo
Design
Meta-analysis, randomised controlled trials, double-blind
Authors
Loading...
Avoid routine perioperative beta-blockade in vascular surgery; confirms no event reduction in Level 1 evidence.
Does perioperative beta-adrenergic blockade reduce cardiac morbidity and mortality in adults undergoing major non-cardiac vascular surgery?
Perioperative beta-blockade with metoprolol does not reduce cardiac morbidity or mortality in major vascular surgery but significantly increases the risk of intra-operative bradycardia and hypotension.
Mostafaie et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: